Bavarian Nordic A/S - Corporate Headquarters
3490 Kvistgård, Denmark
Bavarian Nordic A/S - Corporate Headquarters Company Information
General information
Through long-standing collaborations, including a collaboration with the U.S. government, Bavarian Nordic has developed a portfolio of vaccines for infectious diseases, including the non-replicating smallpox vaccine, IMVAMUNE®, which is stockpiled for emergency use by the United States and other governments. The vaccine is approved in the European Union (under the trade name IMVANEX®) and in Canada. Bavarian Nordic and its partner Janssen are developing an Ebola vaccine regimen, which has been fast-tracked, with the backing of worldwide health authorities. Additionally, in collaboration with the National Cancer Institute, Bavarian Nordic has developed a portfolio of active cancer immunotherapies, including PROSTVAC®, which is currently in Phase 3 clinical development for the treatment of advanced prostate cancer. The company has partnered with Bristol-Myers Squibb for the potential commercialization of PROSTVAC.
Hejreskovvej 10A Kvistgård
- Opening hours
-
Monday:08:00 - 16:00Tuesday:08:00 - 16:00Wednesday:08:00 - 16:00Thursday:08:00 - 16:00Friday:08:00 - 16:00
- Parking
- The company has a parking lot.
- Phone number
- +4533268383
- Linki
- Social Accounts
- Keywords
- pharmaceutical company
Bavarian Nordic A/S - Corporate Headquarters Reviews & Ratings
How do you rate this company?
Are you the owner of this company? If so, do not lose the opportunity to update your company's profile, add products, offers and higher position in search engines.